Literature DB >> 8566865

Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas.

P A Jackson1, M A Green, C G Marks, R J King, R Hubbard, M G Cook.   

Abstract

Fifty eight large bowel adenocarcinomas and 20 adenomas were studied immunohistochemically, using fresh frozen tissue sections, with regard to lymphocyte subpopulations (CD3, CD4, CD8, CD19, and CD20) in the inflammatory infiltrate and to expression of human leucocyte antigens (HLA-ABC, HLA-A2, and HLA-DR). The findings were related to differentiation and Duke's stage of carcinoma. The inflammatory infiltrate was found to have a phenotype that remained constant irrespective of the intensity of the inflammation. CD4 and CD3 positive cells predominated with fewer CD8 positive cells and a scanty diffuse CD19/20 positive cell population. CD19/20 follicular aggregates were common at the advancing margin of the carcinomas. There was no significant association with Duke's stage, differentiation or HLA status. HLA changes (ABC loss, A2 loss, and DR gain) were associated with differentiation, being more common and more extensive in poorly differentiated carcinomas. HLA-A2 loss was also associated with stage of progression of carcinoma. Inflammation associated with adenomas was found to have a similar phenotype to that associated with carcinomas. HLA changes in adenomas were uncommon, being seen in only one of our 20 cases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566865      PMCID: PMC1382984          DOI: 10.1136/gut.38.1.85

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Expression of HLA-D sub-region products on human colorectal carcinoma.

Authors:  A K Ghosh; M Moore; A J Street; J M Howat; P F Schofield
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

2.  The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials.

Authors:  N Wolmark; B Fisher; H S Wieand
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

3.  A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer.

Authors:  P H Chapuis; O F Dent; R Fisher; R C Newland; M T Pheils; E Smyth; K Colquhoun
Journal:  Br J Surg       Date:  1985-09       Impact factor: 6.939

4.  The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients.

Authors:  A Di Giorgio; C Botti; A Tocchi; P Mingazzini; M Flammia
Journal:  Int Surg       Date:  1992 Oct-Dec

5.  Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area.

Authors:  B Ostenstad; T Lea; E Schlichting; M Harboe
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

6.  An immunophenotypic study of the inflammatory cell populations in colon adenomas and carcinomas.

Authors:  B F Banner; E Sonmez-Alpan; S A Yousem
Journal:  Mod Pathol       Date:  1993-05       Impact factor: 7.842

7.  Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans.

Authors:  H C Umpleby; D Heinemann; M O Symes; R C Williamson
Journal:  J Natl Cancer Inst       Date:  1985-06       Impact factor: 13.506

8.  Characterization of the inflammatory cell populations in normal colon and colonic carcinomas.

Authors:  B F Banner; L Savas; S Baker; B A Woda
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

9.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Authors:  J R Jass; W S Atkin; J Cuzick; H J Bussey; B C Morson; J M Northover; I P Todd
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

10.  Lymphocytic infiltration and survival in rectal cancer.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

View more
  6 in total

1.  Clinical significance of changes of perioperative T cell and expression of its activatedantigen in colorectal cancer patients.

Authors:  Yi-Xing Wang; Can-Ping Ruan; Li Li; Jing-Hua Shi; Xian-Tao Kong
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

Review 2.  B cells, plasma cells and antibody repertoires in the tumour microenvironment.

Authors:  George V Sharonov; Ekaterina O Serebrovskaya; Diana V Yuzhakova; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Rev Immunol       Date:  2020-01-27       Impact factor: 53.106

3.  Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Authors:  S M Todryk; H Chong; R G Vile; H Pandha; N R Lemoine
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

4.  Altered time structure of neuro-endocrine-immune system function in lung cancer patients.

Authors:  Gianluigi Mazzoccoli; Gianluigi Vendemiale; Angelo De Cata; Stefano Carughi; Roberto Tarquini
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

5.  Fas ligand expression in lynch syndrome-associated colorectal tumours.

Authors:  Jan J Koornstra; Steven de Jong; Wietske Boersma-van Eck; Nynke Zwart; Harry Hollema; Elisabeth G E de Vries; Jan H Kleibeuker
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 6.  Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients.

Authors:  Francesco Sabbatino; Luigi Liguori; Giovanna Polcaro; Ilaria Salvato; Gaetano Caramori; Francesco A Salzano; Vincenzo Casolaro; Cristiana Stellato; Jessica Dal Col; Stefano Pepe
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.